| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | POU domain binding | 1.23e-04 | 7 | 49 | 2 | GO:0070974 | |
| GeneOntologyMolecularFunction | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 4.52e-04 | 13 | 49 | 2 | GO:0001162 | |
| GeneOntologyMolecularFunction | cytokine binding | 5.92e-04 | 157 | 49 | 4 | GO:0019955 | |
| GeneOntologyMolecularFunction | intronic transcription regulatory region sequence-specific DNA binding | 7.84e-04 | 17 | 49 | 2 | GO:0001161 | |
| GeneOntologyBiologicalProcess | trophectodermal cell fate commitment | 1.73e-05 | 3 | 50 | 2 | GO:0001830 | |
| GeneOntologyBiologicalProcess | ectodermal cell fate commitment | 5.73e-05 | 5 | 50 | 2 | GO:0001712 | |
| GeneOntologyBiologicalProcess | ectoderm formation | 1.20e-04 | 7 | 50 | 2 | GO:0001705 | |
| GeneOntologyBiologicalProcess | ectodermal cell differentiation | 2.05e-04 | 9 | 50 | 2 | GO:0010668 | |
| GeneOntologyBiologicalProcess | germ-line stem cell population maintenance | 2.56e-04 | 10 | 50 | 2 | GO:0030718 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 3.12e-04 | 11 | 50 | 2 | GO:0001714 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion-dependent exocytosis | 3.12e-04 | 11 | 50 | 2 | GO:0045955 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 3.22e-04 | 55 | 50 | 3 | GO:0060071 | |
| Domain | POU_dom_5 | 1.70e-08 | 3 | 49 | 3 | IPR015585 | |
| Domain | GPS | 1.83e-06 | 34 | 49 | 4 | SM00303 | |
| Domain | GPS | 2.06e-06 | 35 | 49 | 4 | PF01825 | |
| Domain | GPS | 2.32e-06 | 36 | 49 | 4 | PS50221 | |
| Domain | GPS | 2.59e-06 | 37 | 49 | 4 | IPR000203 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 8.81e-06 | 50 | 49 | 4 | PS00650 | |
| Domain | 7tm_2 | 8.81e-06 | 50 | 49 | 4 | PF00002 | |
| Domain | POU | 9.28e-06 | 16 | 49 | 3 | SM00352 | |
| Domain | POU_2 | 9.28e-06 | 16 | 49 | 3 | PS00465 | |
| Domain | POU_dom | 9.28e-06 | 16 | 49 | 3 | IPR000327 | |
| Domain | POU_3 | 9.28e-06 | 16 | 49 | 3 | PS51179 | |
| Domain | Pou | 9.28e-06 | 16 | 49 | 3 | PF00157 | |
| Domain | POU_1 | 9.28e-06 | 16 | 49 | 3 | PS00035 | |
| Domain | POU | 1.12e-05 | 17 | 49 | 3 | IPR013847 | |
| Domain | GPCR_2_secretin-like | 1.83e-05 | 60 | 49 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 1.83e-05 | 60 | 49 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.95e-05 | 61 | 49 | 4 | PS50261 | |
| Domain | - | 4.75e-05 | 27 | 49 | 3 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 5.91e-05 | 29 | 49 | 3 | IPR010982 | |
| Domain | ASX_HYDROXYL | 1.36e-04 | 100 | 49 | 4 | PS00010 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.57e-04 | 40 | 49 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 1.57e-04 | 40 | 49 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.57e-04 | 40 | 49 | 3 | PS50227 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.71e-04 | 106 | 49 | 4 | IPR000152 | |
| Domain | EGF_CA | 2.93e-04 | 122 | 49 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.11e-04 | 124 | 49 | 4 | IPR001881 | |
| Domain | GAIN_dom_N | 3.65e-04 | 11 | 49 | 2 | IPR032471 | |
| Domain | GAIN | 3.65e-04 | 11 | 49 | 2 | PF16489 | |
| Domain | Growth_fac_rcpt_ | 7.41e-04 | 156 | 49 | 4 | IPR009030 | |
| Domain | HormR | 1.95e-03 | 25 | 49 | 2 | SM00008 | |
| Domain | hEGF | 2.44e-03 | 28 | 49 | 2 | PF12661 | |
| Domain | HRM | 2.44e-03 | 28 | 49 | 2 | PF02793 | |
| Domain | EGF_LAM_2 | 2.80e-03 | 30 | 49 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 2.80e-03 | 30 | 49 | 2 | PS01248 | |
| Domain | EGF_3 | 3.32e-03 | 235 | 49 | 4 | PS50026 | |
| Domain | EGF | 3.32e-03 | 235 | 49 | 4 | SM00181 | |
| Domain | Laminin_EGF | 3.80e-03 | 35 | 49 | 2 | PF00053 | |
| Domain | EGF_Lam | 3.80e-03 | 35 | 49 | 2 | SM00180 | |
| Domain | EGF-like_dom | 4.08e-03 | 249 | 49 | 4 | IPR000742 | |
| Domain | EGF_1 | 4.44e-03 | 255 | 49 | 4 | PS00022 | |
| Domain | LAM_G_DOMAIN | 4.46e-03 | 38 | 49 | 2 | PS50025 | |
| Domain | Laminin_EGF | 4.46e-03 | 38 | 49 | 2 | IPR002049 | |
| Domain | EGF-like_CS | 4.82e-03 | 261 | 49 | 4 | IPR013032 | |
| Domain | Laminin_G_2 | 4.94e-03 | 40 | 49 | 2 | PF02210 | |
| Domain | EGF_2 | 5.09e-03 | 265 | 49 | 4 | PS01186 | |
| Domain | LamG | 5.95e-03 | 44 | 49 | 2 | SM00282 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.63e-07 | 33 | 51 | 4 | 25713288 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31843009 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 29266259 | ||
| Pubmed | The Effect of Melatonin on OCT4 Expression and Granulosa Cell Growth in Female Mice. | 2.11e-06 | 2 | 51 | 2 | 34735714 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12110668 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31277213 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 35501657 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15685634 | ||
| Pubmed | Nucleosome Clutches are Regulated by Chromatin Internal Parameters. | 2.11e-06 | 2 | 51 | 2 | 33181171 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 26832419 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 37895112 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 16950240 | ||
| Pubmed | Maternal Oct-4 is a potential key regulator of the developmental competence of mouse oocytes. | 2.11e-06 | 2 | 51 | 2 | 18837968 | |
| Pubmed | The homeodomain of Oct4 is a dimeric binder of methylated CpG elements. | 2.11e-06 | 2 | 51 | 2 | 36631980 | |
| Pubmed | [Investigation of transcriptional regulation of Oct4 (POU5F1) gene with distal enhancer]. | 2.11e-06 | 2 | 51 | 2 | 25509123 | |
| Pubmed | Cruciform Formable Sequences within Pou5f1 Enhancer Are Indispensable for Mouse ES Cell Integrity. | 2.11e-06 | 2 | 51 | 2 | 33810223 | |
| Pubmed | Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. | 2.11e-06 | 2 | 51 | 2 | 18063756 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22120493 | ||
| Pubmed | Analysis of a transgenic Oct4 enhancer reveals high fidelity long-range chromosomal interactions. | 2.11e-06 | 2 | 51 | 2 | 26435056 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19664601 | ||
| Pubmed | Distinct Enhancer Activity of Oct4 in Naive and Primed Mouse Pluripotency. | 2.11e-06 | 2 | 51 | 2 | 28157483 | |
| Pubmed | Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. | 2.11e-06 | 2 | 51 | 2 | 9507072 | |
| Pubmed | Isolation of Oct4-expressing extraembryonic endoderm precursor cell lines. | 2.11e-06 | 2 | 51 | 2 | 19784378 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 28988986 | ||
| Pubmed | Abnormal DNA methylation of the Oct-4 enhancer region in cloned mouse embryos. | 2.11e-06 | 2 | 51 | 2 | 18932201 | |
| Pubmed | Oct-3/4 repression accelerates differentiation of neural progenitor cells in vitro and in vivo. | 2.11e-06 | 2 | 51 | 2 | 15548425 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 25043178 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 36130732 | ||
| Pubmed | A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. | 2.11e-06 | 2 | 51 | 2 | 1972777 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 1915274 | ||
| Pubmed | Mouse Oct-3 maps between the tcl12 embryonic lethal gene and the Qa gene in the H-2 complex. | 2.11e-06 | 2 | 51 | 2 | 1680810 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31222057 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20376339 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30653498 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9835353 | ||
| Pubmed | Effect of ploidy and parental genome composition on expression of Oct-4 protein in mouse embryos. | 2.11e-06 | 2 | 51 | 2 | 15183310 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30209362 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15996113 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34788058 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21083502 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24104477 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 26804242 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21502535 | ||
| Pubmed | Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. | 2.11e-06 | 2 | 51 | 2 | 17525163 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 14990861 | ||
| Pubmed | OCT4 Acts as an Integrator of Pluripotency and Signal-Induced Differentiation. | 2.11e-06 | 2 | 51 | 2 | 27499297 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 16772384 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11839818 | ||
| Pubmed | Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. | 2.11e-06 | 2 | 51 | 2 | 24561253 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34948221 | ||
| Pubmed | Auxin-degron system identifies immediate mechanisms of OCT4. | 2.11e-06 | 2 | 51 | 2 | 34143975 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 27302093 | ||
| Pubmed | Characterization of a negative retinoic acid response element in the murine Oct4 promoter. | 2.11e-06 | 2 | 51 | 2 | 8289793 | |
| Pubmed | Force via integrins but not E-cadherin decreases Oct3/4 expression in embryonic stem cells. | 2.11e-06 | 2 | 51 | 2 | 22037576 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31624145 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22704655 | ||
| Pubmed | Oct4 redox sensitivity potentiates reprogramming and differentiation. | 2.11e-06 | 2 | 51 | 2 | 38719541 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 33221301 | ||
| Pubmed | Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences. | 2.11e-06 | 2 | 51 | 2 | 11309664 | |
| Pubmed | Developmental fate of embryonic germ cells (EGCs), in vivo and in vitro. | 2.11e-06 | 2 | 51 | 2 | 12641567 | |
| Pubmed | Post-translational regulation of Oct4 transcriptional activity. | 2.11e-06 | 2 | 51 | 2 | 19221599 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21285944 | ||
| Pubmed | A nontranscriptional role for Oct4 in the regulation of mitotic entry. | 2.11e-06 | 2 | 51 | 2 | 25324523 | |
| Pubmed | A novel subpopulation lacking Oct4 expression in the testicular side population. | 2.11e-06 | 2 | 51 | 2 | 16328007 | |
| Pubmed | A unique Oct4 interface is crucial for reprogramming to pluripotency. | 2.11e-06 | 2 | 51 | 2 | 23376973 | |
| Pubmed | Oct4 kinetics predict cell lineage patterning in the early mammalian embryo. | 2.11e-06 | 2 | 51 | 2 | 21258368 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23580657 | ||
| Pubmed | Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. | 2.11e-06 | 2 | 51 | 2 | 17724450 | |
| Pubmed | Novel variants of Oct-3/4 gene expressed in mouse somatic cells. | 2.11e-06 | 2 | 51 | 2 | 18765667 | |
| Pubmed | Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells. | 2.11e-06 | 2 | 51 | 2 | 18283123 | |
| Pubmed | Transcriptional activation by Oct4 is sufficient for the maintenance and induction of pluripotency. | 2.11e-06 | 2 | 51 | 2 | 22832160 | |
| Pubmed | Gonadotropins affect Oct-4 gene expression during mouse oocyte growth. | 2.11e-06 | 2 | 51 | 2 | 16496425 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 16932739 | ||
| Pubmed | A conserved Oct4/POUV-dependent network links adhesion and migration to progenitor maintenance. | 2.11e-06 | 2 | 51 | 2 | 24210613 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15955835 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34463738 | ||
| Pubmed | Differential expression of Oct3/4 in human breast cancer and normal tissues. | 2.11e-06 | 2 | 51 | 2 | 29620155 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20412747 | ||
| Pubmed | Oct4 promoter activity in stem cells obtained through somatic reprogramming. | 2.11e-06 | 2 | 51 | 2 | 23550731 | |
| Pubmed | Glutamine Metabolism Regulates the Pluripotency Transcription Factor OCT4. | 2.11e-06 | 2 | 51 | 2 | 27346346 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30762028 | ||
| Pubmed | POU-V factors antagonize maternal VegT activity and beta-Catenin signaling in Xenopus embryos. | 2.11e-06 | 2 | 51 | 2 | 17541407 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 26615201 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 17932422 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22730289 | ||
| Pubmed | Secondary structure of the oct-3 POU homeodomain as determined by 1H-15N NMR spectroscopy. | 2.11e-06 | 2 | 51 | 2 | 8097478 | |
| Pubmed | Identification of a homologue of POU5F1 (OCT3/4) in a marsupial, the brushtail possum. | 2.11e-06 | 2 | 51 | 2 | 11170265 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 32930837 | ||
| Pubmed | Dissecting Oct3/4-regulated gene networks in embryonic stem cells by expression profiling. | 2.11e-06 | 2 | 51 | 2 | 17183653 | |
| Pubmed | A novel variant of Oct3/4 gene in mouse embryonic stem cells. | 2.11e-06 | 2 | 51 | 2 | 22683460 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23963638 | ||
| Pubmed | In silico tandem affinity purification refines an Oct4 interaction list. | 2.11e-06 | 2 | 51 | 2 | 21569470 | |
| Pubmed | Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming. | 2.11e-06 | 2 | 51 | 2 | 26877091 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12615074 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19641521 | ||
| Pubmed | OCT4 expression mediates partial cardiomyocyte reprogramming of mesenchymal stromal cells. | 2.11e-06 | 2 | 51 | 2 | 29216265 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22367590 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20439621 | ||
| Pubmed | Loss of Oct4 expression during the development of murine embryoid bodies. | 2.11e-06 | 2 | 51 | 2 | 22960235 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20219939 | ||
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.15e-05 | 3 | 36 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.15e-05 | 3 | 36 | 2 | 1189 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 1.25e-05 | 23 | 36 | 3 | 523 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.64e-05 | 133 | 51 | 4 | 29b0c2c682c6b97823e7d8d8ba1f5114044b30ba | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.18e-05 | 169 | 51 | 4 | bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.38e-05 | 171 | 51 | 4 | 7b0783d25055e5ea5b2fc44ebcb16bfd0adbcf81 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.95e-05 | 185 | 51 | 4 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-05 | 186 | 51 | 4 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | facs-Lung|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-05 | 188 | 51 | 4 | f7292fc8e914f222828dcdb0a017d716207a97f6 | |
| ToppCell | facs-Lung|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 188 | 51 | 4 | e2b6e14579ec649a2bc106d9c99bb78ceb16ede3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 189 | 51 | 4 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.59e-05 | 190 | 51 | 4 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.59e-05 | 190 | 51 | 4 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.59e-05 | 190 | 51 | 4 | 2803eb02209591a63fe13e834e4e0f8014e1aa34 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.73e-05 | 191 | 51 | 4 | 38fe60a8570f3c6eb8e8f8646f90d505dfd7d647 | |
| ToppCell | PND01-Endothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.73e-05 | 191 | 51 | 4 | 96b9b0aaf0cb2d6f929ff563dbaedc83ffb4795e | |
| ToppCell | Endothelial-B|World / shred on cell class and cell subclass (v4) | 6.73e-05 | 191 | 51 | 4 | 8b7857dee69d0ba3e59e230c9fd372e14695299e | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.73e-05 | 191 | 51 | 4 | 0e6cd2628a5cebd35e960e4eb3b52ddc9358031c | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.87e-05 | 192 | 51 | 4 | 8ad6678df89175c5a4a835c8566f1552df3c996e | |
| ToppCell | Endothelial|World / shred on cell class and cell subclass (v4) | 6.87e-05 | 192 | 51 | 4 | 2b13cca5c4b58628dbbbb356859632dba66d43f9 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.87e-05 | 192 | 51 | 4 | 2f5378ea0b2fb2f672a36585d375f675983363a1 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 193 | 51 | 4 | 30254658a2023ea9808cdd786530b966a1446418 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 193 | 51 | 4 | b7c0b4dbbe11f86cff6371d3d12a6b772b938d78 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 193 | 51 | 4 | b6b065b0c2ad31d1488dfa970450b29a8ac1f3aa | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 193 | 51 | 4 | e44d777f65b907f299cefd73296805ac4c92d383 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.01e-05 | 193 | 51 | 4 | f27e2be497745098b5269aa799dd3d5f62d78ba7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.01e-05 | 193 | 51 | 4 | 4ccf984baebbb13ae916727137ce593fda7514a2 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 193 | 51 | 4 | 4513e6cb3f86d9cc56e7892fbe11a861335bd179 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.15e-05 | 194 | 51 | 4 | f93f5148b136819d87faef89707dbaba07d6c2b5 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-05 | 195 | 51 | 4 | d700e959e060932e3854a9cf294799465efbe18b | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 195 | 51 | 4 | e5f14f6015ea5e6fa065f906ad22157e3de15c68 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 195 | 51 | 4 | 52b2bbf12e5f86c493f6634697aeb23a68cc916d | |
| ToppCell | PND03-Endothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.44e-05 | 196 | 51 | 4 | a529681d822a95dd1980b7b1c71dc61aaf0baecd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 196 | 51 | 4 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.71e-05 | 222 | 50 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.95e-05 | 225 | 50 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.26e-05 | 239 | 50 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.26e-04 | 57 | 50 | 3 | EFO_0022284 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 1.39e-04 | 59 | 50 | 3 | EFO_0022289 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 7.39e-04 | 104 | 50 | 3 | EFO_0008591, EFO_0008595 | |
| Disease | fatty acid measurement | 8.44e-04 | 436 | 50 | 5 | EFO_0005110 | |
| Disease | apolipoprotein B measurement | 8.63e-04 | 663 | 50 | 6 | EFO_0004615 | |
| Disease | very low density lipoprotein cholesterol measurement | 9.87e-04 | 260 | 50 | 4 | EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.04e-03 | 264 | 50 | 4 | EFO_0008317, EFO_0020944 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.49e-03 | 291 | 50 | 4 | EFO_0008317, EFO_0020946 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.64e-03 | 137 | 50 | 3 | EFO_0004611, EFO_0008591 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.73e-03 | 303 | 50 | 4 | EFO_0004612, EFO_0020945 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 2.00e-03 | 39 | 50 | 2 | EFO_0022332 | |
| Disease | cholesterol in very small VLDL measurement | 2.11e-03 | 40 | 50 | 2 | EFO_0022231 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.36e-03 | 330 | 50 | 4 | EFO_0004529, EFO_0004612 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 2.66e-03 | 45 | 50 | 2 | EFO_0022236 | |
| Disease | total lipids in very small VLDL measurement | 2.66e-03 | 45 | 50 | 2 | EFO_0022156 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.78e-03 | 46 | 50 | 2 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | free cholesterol in very small VLDL measurement | 2.90e-03 | 47 | 50 | 2 | EFO_0022275 | |
| Disease | total lipids in lipoprotein particles measurement | 3.02e-03 | 48 | 50 | 2 | EFO_0022309 | |
| Disease | phospholipids in very small VLDL measurement | 3.40e-03 | 51 | 50 | 2 | EFO_0022300 | |
| Disease | phospholipids in IDL measurement | 3.53e-03 | 52 | 50 | 2 | EFO_0022164 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 3.67e-03 | 53 | 50 | 2 | EFO_0022340 | |
| Disease | total phospholipids in lipoprotein particles measurement | 3.67e-03 | 53 | 50 | 2 | EFO_0022315 | |
| Disease | HMG CoA reductase inhibitor use measurement | 4.06e-03 | 189 | 50 | 3 | EFO_0009932 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 4.09e-03 | 56 | 50 | 2 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 4.09e-03 | 56 | 50 | 2 | EFO_0022250 | |
| Disease | cholesterol in IDL measurement | 4.38e-03 | 58 | 50 | 2 | EFO_0021899 | |
| Disease | total lipids in IDL | 4.68e-03 | 60 | 50 | 2 | EFO_0022161 | |
| Disease | free cholesterol in IDL measurement | 4.83e-03 | 61 | 50 | 2 | EFO_0022181 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WSSLCLGPAPAPPGP | 36 | Q9BRR6 | |
| EPWFPPAPDGSCPGL | 646 | Q8WWN8 | |
| MVPGPARPPGSCWDP | 21 | Q6RUI8 | |
| CRPGWQPIPGSPNGP | 191 | Q9UHX3 | |
| CAQDPSPAARWPPGP | 21 | Q8TAV3 | |
| WAPCPLPVGPGPAWI | 961 | Q5JTC6 | |
| LPCPRGWWGNPVCGP | 1951 | Q9NYQ6 | |
| IPLPPAPEGCPWSCR | 101 | Q9HCU4 | |
| PEWPPLASCGVPPFQ | 111 | Q9NXF7 | |
| VPLQEAWGPPPGPCR | 856 | Q7Z5Q5 | |
| PATPPPWGCPLGRLV | 101 | Q01201 | |
| PGAQPPALEGPWSPR | 106 | Q8IW93 | |
| VGPGSEVWGIPPCPP | 51 | Q06416 | |
| PRPHPWGCPAGEPWV | 86 | P56730 | |
| REPPLGAAGDWPPCL | 1986 | P78559 | |
| VCWEQQLRPGGPGPP | 156 | Q9HCH0 | |
| NGELCGPPQPEPSPW | 226 | Q9HCH0 | |
| WPCPQPPSPGMLCLG | 1601 | Q6ZU64 | |
| WRPPACRSPLPPGGD | 471 | Q96JJ6 | |
| PLPFPPAGGCWSPLV | 1566 | O94915 | |
| GCHCPGDAPWRPPPP | 16 | P57055 | |
| VWPAVRPGICPGPDV | 46 | Q8N7G0 | |
| SPAAPCPPRPWQLGV | 21 | P23434 | |
| PPLCAHQPLLGPWGR | 16 | Q86XE3 | |
| LPWPGQPIRGCRGPQ | 1211 | Q9C091 | |
| LGPPCAGCPWPTAGP | 316 | Q02080 | |
| VGPGSEVWGIPPCPP | 51 | Q01860 | |
| QCNPPPGLPSPVIFW | 161 | O94856 | |
| EGWPPWVGPCFPELR | 426 | P81408 | |
| PCILEPCPGPSWQGP | 361 | O43603 | |
| PSKGPGNIPRGDPPW | 651 | Q0VDD7 | |
| WPGPLACPQGPAPLA | 181 | Q8WZ55 | |
| PGGPPLWERPAFSQP | 276 | P0CW27 | |
| PWVPGPSGRDCQLPE | 1111 | Q9NS15 | |
| SPPPPPGCWGCWQKG | 251 | Q9Y5N1 | |
| PLWALPGGDAECPGP | 461 | P40197 | |
| PPAPEPPWHCGDRGD | 361 | O15037 | |
| WRAPGGDPCQPLVPP | 401 | Q8NAC3 | |
| QPPWCDPLGPFVVGG | 181 | Q92530 | |
| PEGAREPPWPALPPC | 11 | O43193 | |
| CPRRWLPEGPVPQSP | 21 | A5PKW4 | |
| GPAPACPEAWGSPEP | 1191 | O15061 | |
| PNPPNPSGQCPICRW | 61 | Q9NVS2 | |
| PVPSEECPTWNPGPR | 326 | Q7Z7M1 | |
| VTWVEEPCGPGPPQP | 31 | Q8IZ52 | |
| QPWGAPWTGPFCPDP | 466 | O14924 | |
| LVEGRSCGWVPPPPG | 61 | P26651 | |
| SCGWVPPPPGFAPLA | 66 | P26651 | |
| AGVRCWEPGPGPPLP | 881 | Q4G0T1 | |
| APGAEPAQPPCPWPV | 131 | B2RXF5 | |
| RPGWLPQPSSPGPAC | 91 | Q8N0V1 | |
| GVPLCAPDPGSEPPW | 226 | Q96C55 | |
| QGCPWAPGPAPCLLP | 336 | Q9BRZ2 | |
| APLPPRDPNGAGPEW | 6 | Q96H86 | |
| WYPPEPGPCWRPGPH | 256 | Q96P71 |